Akkuş-Dağdeviren Zeynep Burcu, Wolf Julian Dominik, Kurpiers Markus, Shahzadi Iram, Steinbring Christian, Bernkop-Schnürch Andreas
Center for Chemistry and Biomedicine, Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Center for Chemistry and Biomedicine, Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria; Thiomatrix Forschungs-und Beratungs GmbH, Trientlgasse 65, 6020 Innsbruck, Austria.
J Colloid Interface Sci. 2021 May;589:532-544. doi: 10.1016/j.jcis.2021.01.025. Epub 2021 Jan 13.
Phosphorylated surfactants having ethoxylate spacer arms are promising excipients for charge reversal self-emulsifying drug delivery systems (SEDDS).
1,2-Dipalmitoyl-sn-glycero-3-phosphatidic acid disodium salt (PA), 2-((2,3-bis(oleoyloxy)propyl)dimethylammonio)ethyl hydrogen phosphate (DOCP), nonylphenol monophosphate ester (PNPP), C12-15 alcohol 3 ethoxylate phosphate ester (PME) and polyoxyethylene (9) dioctanoyl glycerol pyrophosphate (DGPP) loaded SEDDS were developed and characterized. Zeta potential of SEDDS was measured before and after incubation with intestinal alkaline phosphatase (IAP). Phosphate release was monitored by incubation of SEDDS with isolated as well as cell-associated IAP. Primary amine content on the surface of SEDDS was determined in parallel. Cytotoxicity was evaluated on Caco-2 cells and in vitro hemolysis test was performed. Cellular uptake studies were performed by confocal scanning microscopy.
SEDDS formulations exhibited a size in the range of 17 and 193 nm and a polydispersity index (PDI) ≤ 0.5. Charge reversal from negative to positive values could be achieved in case of PNPP and PME loaded SEDDS with a zeta potential changing from -13 mV to +9 mV and from -7 to +2 mV, respectively, within 6 h. Significant amounts of phosphate were released from PNPP and PME loaded SEDDS incubated with isolated IAP and from all formulations incubated with cell-associated IAP in accordance with an increase in primary amines on the surface of oily droplets. SEDDS exhibited a concentration and time-dependent cytotoxicity. PNPP and PME SEDDS displayed an increased cellular uptake.
具有乙氧基化间隔臂的磷酸化表面活性剂是电荷反转自乳化药物递送系统(SEDDS)中很有前景的辅料。
开发并表征了负载1,2 - 二棕榈酰 - sn - 甘油 - 3 - 磷酸二钠盐(PA)、2 - ((2,3 - 双(油酰氧基)丙基)二甲基铵基)乙基磷酸氢盐(DOCP)、壬基酚单磷酸酯(PNPP)、C12 - 15醇3乙氧基化磷酸酯(PME)和聚氧乙烯(9)二辛酰甘油焦磷酸酯(DGPP)的SEDDS。在与肠道碱性磷酸酶(IAP)孵育前后测量SEDDS的zeta电位。通过将SEDDS与分离出的以及与细胞相关的IAP孵育来监测磷酸盐释放。同时测定SEDDS表面的伯胺含量。在Caco - 2细胞上评估细胞毒性并进行体外溶血试验。通过共聚焦扫描显微镜进行细胞摄取研究。
SEDDS制剂的粒径在17至193 nm范围内,多分散指数(PDI)≤0.5。对于负载PNPP和PME的SEDDS,在6小时内zeta电位分别从 - 13 mV变为 + 9 mV和从 - 7 mV变为 + 2 mV,可实现从负值到正值的电荷反转。与分离出的IAP孵育的负载PNPP和PME的SEDDS以及与细胞相关的IAP孵育的所有制剂中,随着油滴表面伯胺的增加,有大量磷酸盐释放。SEDDS表现出浓度和时间依赖性细胞毒性。PNPP和PME SEDDS显示细胞摄取增加。